-
公开(公告)号:US20250066796A1
公开(公告)日:2025-02-27
申请号:US18948183
申请日:2024-11-14
Applicant: Baylor College of Medicine
Inventor: Laising Yen , Liming Luo , Pei-Wen Chao
IPC: C12N15/115 , A61K48/00 , C12N15/67
Abstract: Embodiments of the disclosure concern the use of expression constructs in which at least one polyA signal is embedded upstream of an expressible transcript, such as within a 5′ UTR for the transcript, for example. In certain embodiments, the polyA signal is comprised within a ligand-binding aptamer, and the binding of the ligand to the aptamer, or lack thereof, dictates the outcome for the expressible transcript. In specific embodiments, absence of the ligand causes the expressed transcript having a polyA in its 5′ UTR to be expressed but then degraded, whereas presence of the ligand causes inhibition of degradation upon expression of the expressible transcript. More than one ligand-binding aptamer may be present on the same expression construct.
-
公开(公告)号:US12215335B2
公开(公告)日:2025-02-04
申请号:US16648885
申请日:2018-09-17
Applicant: Deutsches Krebsforschungszentrum
Inventor: James A. Williams , Matthias Bozza , Richard Harbottle
Abstract: The present invention relates to a polynucleotide comprising at least one promoter and an S/MAR element, wherein the S/MAR element is located downstream of the promoter in the 3′ UTR of the transcription unit and wherein the S/MAR element is flanked by a 5′ splice donor site and a 3′ splice acceptor site; the present invention further relates to a composition comprising the polynucleotide, and to the polynucleotide for use in medicine and for use in treating genetic disease.
-
公开(公告)号:US12151988B2
公开(公告)日:2024-11-26
申请号:US16759231
申请日:2018-10-25
Applicant: Pivot Bio, Inc.
Inventor: Alvin Tamsir , Sarah Bloch , Neal Shah
Abstract: Methods and systems are provided for generating and utilizing a genetically engineered bacterium comprising a modification in glnD, wherein said modification is selected from the group consisting of: deletion of the entire gene, deletion of substantially the entire gene, deletion of an ACT domain, deletion of more than 50% of an ACT domain, deactivation of an ACT domain, and deactivation of an UTase domain.
-
公开(公告)号:US12139715B2
公开(公告)日:2024-11-12
申请号:US17253401
申请日:2018-06-19
Applicant: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
Inventor: Sang Woo Seo , Jina Yang
IPC: C12N15/67
Abstract: Provided is a gene expression cassette which, for the production of a high-quality recombinant protein in bacteria, initiates translation after completion of transcription, and more specifically, to a gene expression cassette consisting of a switch capable of stopping translation initiation and a trigger system capable of activating the translation initiation from the switch by re-configuring the transcription-translation coupled system inherent in bacteria such that the translation is initiated only by a full-length mRNA chain template. The transcription and translation in the bacteria can be uncoupled by inserting a trigger sequence activating the translation initiation from the switch into the downstream (3′ terminal) of a target recombinant gene by replacing a natural transcription translation-coupled 5′ UTR with the switch. The productivity of a high-quality full-length recombinant protein can be increased while reducing the costs associated with a purification process.
-
公开(公告)号:US20240368608A1
公开(公告)日:2024-11-07
申请号:US18033639
申请日:2021-10-26
Applicant: KAO CORPORATION
Inventor: Hiroki NISHIGUCHI , Akihito KAWAHARA
Abstract: A nucleic acid construct includes a polynucleotide encoding a protein of interest and a polynucleotide linked upstream of the polynucleotide and encoding a modified signal peptide. The modified signal peptide includes amino acid residues of X1X2X3X4X5X6 at positions 1 to 6 as counted from the C-terminus, where X1 is G, P, or A; X2 is G, S, or A; and X3 is P, S, or A, provided that X1X2X3 is not GGP; X4 is A; X5 is S, H, or F; and X6 is A and is located at the C-terminus of the modified signal peptide.
-
6.
公开(公告)号:US20240366792A1
公开(公告)日:2024-11-07
申请号:US18649798
申请日:2024-04-29
Applicant: Duke University , Cold Spring Harbor Laboratory
Inventor: Z. Josh Huang , Yongjun Qian
Abstract: A readrRNA (RNA sensing by Endogenous ADAR) molecule is a modular RNA molecule that facilitates cell sensing and detection of a cell type or cell status and/or facilitates delivery of an effector protein to a selected cell. A composition that includes such a modular RNA molecule and another nucleic acid (linked or unlinked to the modular RNA molecule) is a CellREADR (Cell access through RNA sensing by Endogenous ADAR). readrRNA and CellReadR sense the presence of a selected cell RNA and leverages RNA editing mediated by ADAR (adenosine deaminase acting on RNA) for coupling the detection of a cell-defining RNA with translation of one or more effector proteins in a cell or in a mammal.
-
公开(公告)号:US12134772B2
公开(公告)日:2024-11-05
申请号:US17276320
申请日:2019-09-06
Applicant: Klogenix LLC
Inventor: Ci-Di Chen , Ella Zeldich , Carmela Abraham
IPC: C12N15/67 , A61K31/713 , C12N9/24 , C12N15/113
Abstract: The present disclosure relates to compositions and methods for modulating gene expression and in particular to compositions and methods for increasing expression of Klotho. In certain examples, the present disclosure provides a method of increasing expression of a Klotho gene in a cell the method comprising administering to the cell a binding molecule that binds to an RNA transcript transcribed from a chromosomal region within or near the Klotho gene, wherein the RNA transcript does not encode a Klotho protein.
-
公开(公告)号:US12122995B2
公开(公告)日:2024-10-22
申请号:US16726163
申请日:2019-12-23
Applicant: DNA2.0, INC.
Inventor: Jeremy Minshull , Mark Welch , Sridhar Govindrajan , Maggie Lee , Kate Caves , Jon Ness
IPC: C12N9/12 , C12N1/16 , C12N1/18 , C12N15/10 , C12N15/52 , C12N15/62 , C12N15/63 , C12N15/67 , C12N15/81 , C12N15/85 , C12N15/90 , C12R1/84 , C12R1/865
CPC classification number: C12N1/165 , C12N1/185 , C12N9/12 , C12N9/1241 , C12N15/1082 , C12N15/52 , C12N15/625 , C12N15/63 , C12N15/81 , C12N15/815 , C12N15/85 , C12N15/8509 , C12N15/90 , C12Y207/00 , C12Y207/07 , C07K2319/09 , C12N15/67 , C12N2800/90 , C12N2830/007 , C12N2830/40 , C12N2830/42 , C12N2840/203 , C12R2001/84 , C12R2001/865
Abstract: The present invention provides polynucleotide vectors for high expression of heterologous genes. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, gene expression, bioprocessing, gene therapy, insertional mutagenesis, or gene discovery.
-
公开(公告)号:US12121531B2
公开(公告)日:2024-10-22
申请号:US17519120
申请日:2021-11-04
Applicant: Flagship Pioneering Innovations VI, LLC
Inventor: Theonie Anastassiadis , David Charles Donnell Butler , Neil Kubica , Qingyi Li
IPC: A61K31/7088 , A61K31/712 , A61K31/7125 , C12N15/11 , C12N15/67
CPC classification number: A61K31/7088 , A61K31/712 , A61K31/7125 , C12N15/11 , C12N15/67 , C12N2310/313 , C12N2310/321 , C12N2310/322
Abstract: The invention relates generally to tRNA-based effector molecules having a non-naturally occurring modification and methods relating thereto.
-
公开(公告)号:US20240344062A1
公开(公告)日:2024-10-17
申请号:US18682754
申请日:2022-08-10
Applicant: THE BROAD INSTITUTE, INC.
Inventor: Ahmed H. Badran , Fan Liu , Sinisa Bratulic
CPC classification number: C12N15/11 , C12N15/1058 , C12N15/67 , C12N15/70
Abstract: The present disclosure relates to compositions, methods and kits for enhancing ribosomal activities in a host cell, especially improvement of the translation activity of heterologous ribosomes within a host cell. Specifically, the instant disclosure provides a number of evolved rRNA sequences, which were remarkably identified to possess enhanced translation activities, improved orthogonal-ribosome binding site (o-RBS) and orthogonal anti-ribosome binding site (o-antiRBS) sequences, host cells possessing deletion or disruption of ribosome hibernation promoting factor (HPF) that thereby exhibit enhanced propagation of selection phage constructs during (PACE), among other aspects. New transgenic organisms harboring heterologous ribosomes and operons are also provided.